Status:
COMPLETED
Overcoming Obstacles in Epigenetic Analysis of Human Twins
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Cardiovascular Risk Factor
Eligibility:
All Genders
1-6 years
Brief Summary
Background Cardiovascular disease is the leading cause of death in the U.S., however scientists have failed to learn fully what are the causes of this disease. A promising lead in understanding the or...
Detailed Description
Cardiovascular disease (CVD) is the leading cause of death in the US, emphasizing an incomplete understanding of its pathology and translation into effective interventions. The fetal origins hypothesi...
Eligibility Criteria
Inclusion
- Monozygotic (preterm or full term) twin infants.
Exclusion
- Infants with major congenital anomalies. Infants from higher birth order (e.g. triplets etc.)
Key Trial Info
Start Date :
September 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04279704
Start Date
September 1 2016
End Date
March 1 2020
Last Update
October 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexis C Wood
Houston, Texas, United States, 77030